Literature DB >> 2648158

Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus.

C A Feener1, M Koenig, L M Kunkel.   

Abstract

Dystrophin is the protein product of the Duchenne/Becker muscular dystrophy locus. It has a relative molecular mass of 427,000 and is encoded by a large RNA transcript processed from more than 65 exons spread over two million base pairs of the human X chromosome. We have used the polymerase chain reaction to see whether any of these exons are used alternatively in the different tissues that express dystrophin. As reported for rat dystrophin, we find that the first exons of the human dystrophin transcript is different in brain and muscle, indicating that dystrophin expression could be differentially regulated in these tissues by usage of distinct promoters. The 3' end of the dystrophin transcript can be alternatively spliced to create numerous isoforms differing at their carboxyl domains; this is the only domain of dystrophin that does not share any similarity with the related cytoskeletal alpha-actinins. These alternative transcripts yield dystrophin molecules which may interact with different proteins of the tissues expressing dystrophin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2648158     DOI: 10.1038/338509a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  93 in total

1.  Isolated dystrophin molecules as seen by electron microscopy.

Authors:  F Pons; N Augier; R Heilig; J Léger; D Mornet; J J Léger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Monoclonal antibodies for dystrophin analysis. Epitope mapping and improved binding to SDS-treated muscle sections.

Authors:  T M Nguyen; I B Ginjaar; G J van Ommen; G E Morris
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

3.  A truncated dystrophin lacking the C-terminal domains is localized at the muscle membrane.

Authors:  T R Helliwell; J M Ellis; R C Mountford; R E Appleton; G E Morris
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

4.  Effect of denervation on regenerating muscle plasma membrane integrity: freeze-fracture and dystrophin immunostaining analyses.

Authors:  T Jimi; Y Wakayama
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

5.  Tissue- and case-specific retention of intron 40 in mature dystrophin mRNA.

Authors:  Atsushi Nishida; Maki Minegishi; Atsuko Takeuchi; Emma Tabe Eko Niba; Hiroyuki Awano; Tomoko Lee; Kazumoto Iijima; Yasuhiro Takeshima; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2015-04-02       Impact factor: 3.172

6.  Differential expression of novel Gs alpha signal transduction protein cDNA species.

Authors:  A Swaroop; N Agarwal; J R Gruen; D Bick; S M Weissman
Journal:  Nucleic Acids Res       Date:  1991-09-11       Impact factor: 16.971

7.  An intact cysteine-rich domain is required for dystrophin function.

Authors:  R D Bies; C T Caskey; R Fenwick
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

8.  Enhanced sensitivity of hippocampal pyramidal neurons from mdx mice to hypoxia-induced loss of synaptic transmission.

Authors:  M F Mehler; K Z Haas; J A Kessler; P K Stanton
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

9.  Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy.

Authors:  T M Nguyen; G E Morris
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

10.  Dystrophin predominantly localizes to the transverse tubule/Z-line regions of single ventricular myocytes and exhibits distinct associations with the membrane.

Authors:  V Peri; B Ajdukovic; P Holland; B S Tuana
Journal:  Mol Cell Biochem       Date:  1994-01-12       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.